Similar articles

• Modified substrates of DNA polymerases and design of antivirals.

  Krayevsky AA, Alexandrova LA, Dyatkina NB, Kukhanova MK, Shirokova EA. Krayevsky AA, et al. Acta Biochim Pol. 1996;43(1):125-32. Acta Biochim Pol. 1996. PMID: 8790718 Review.
• [Development of new enzyme inhibitors for the treatment of AIDS[ ].

  Herdewijn P. Herdewijn P. Verh K Acad Geneeskd Belg. 1992;54(2):139-53. Verh K Acad Geneeskd Belg. 1992. PMID: 1384252 Dutch.
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.

  de Clercq E. de Clercq E. Med Res Rev. 1996 Mar;16(2):125-57. doi: 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2. Med Res Rev. 1996. PMID: 8656777 Review. No abstract available.
• HIV-1 drug resistance. Molecular pathogenesis and laboratory monitoring.

  D'Aquila RT. D'Aquila RT. Clin Lab Med. 1994 Jun;14(2):393-422. Clin Lab Med. 1994. PMID: 7523021 Review.
• Resisting the temptation.

  [No authors listed] [No authors listed] Lancet. 1993 Aug 21;342(8869):448. Lancet. 1993. PMID: 7688842 No abstract available.